Clinical features, management, and outcomes of pulmonary mucormycosis: a decade-long retrospective study from a single center in central China - Scorecard - MDSpire
Advertisement
Clinical features, management, and outcomes of pulmonary mucormycosis: a decade-long retrospective study from a single center in central China
Clinical Scorecard: Clinical Characteristics, Treatment Strategies, and Outcomes of Pulmonary Mucormycosis: A Ten-Year Retrospective Analysis from a Central Chinese Medical Center
At a Glance
Category
Detail
Condition
Pulmonary Mucormycosis
Key Mechanisms
Invasive fungal infection caused by Mucorales, primarily affecting immunocompromised patients.
Target Population
Immunocompromised individuals, particularly those with poorly controlled diabetes.
Care Setting
Inpatient care at a central medical center.
Key Highlights
Mean age of patients: 52.50 years; male predominance: 68.75%.
Common symptoms: cough (100%), expectoration (81.25%), fever (68.75%).
Histopathology confirmed diagnosis in 12 patients; Rhizopus microsporus was the most identified pathogen.
81.25% of patients received systemic antifungal therapy; 75% underwent bronchoscopic debridement or surgery.
12-month survival rate was 81.25%.
Guideline-Based Recommendations
Diagnosis
Use histopathological examination and culture from sterile specimens for proven cases.
Probable cases require clinical and imaging features plus molecular biological testing.
Management
Combination therapy with systemic antifungal agents and surgical/bronchoscopic intervention.
Monitoring & Follow-up
Monitor for clinical symptoms and imaging findings indicative of disease progression.
Risks
High mortality rate ranging from 48% to 87%; complications include sepsis and respiratory failure.
Patient & Prescribing Data
16 inpatients diagnosed with pulmonary mucormycosis.
Combination of amphotericin B formulations and azoles was primarily used.
Clinical Best Practices
Early diagnosis through imaging and histopathology is crucial.
Bronchoscopy is essential for both diagnosis and treatment.
Combination of surgical intervention and antifungal therapy may improve outcomes.
